Laurion Capital Management LP Bridge Bio Pharma, Inc. Transaction History

Laurion Capital Management LP

$8.4 Billion
Q2 2024

A detailed history of Laurion Capital Management LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 4,388,873 shares of BBIO stock, worth $109 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares

4,388,873

Previous 5,176,328 15.21%

Holding current value

$109 Million

Previous $160 Million 30.54%

% of portfolio

1.32%

Previous 1.4%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$23.0 - $31.04 $18.1 Million - $24.4 Million	-787,455 Reduced 15.21%	4,388,873 $111 Million
Q1 2024 May 15, 2024	SELL	$27.35 - $40.45 $1.79 Million - $2.65 Million	-65,505 Reduced 1.25%	5,176,328 $160 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $11.8 Million - $21.6 Million	492,490 Added 10.37%	5,241,833 $212 Million
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $16.4 Million - $22.3 Million	1,236,584 Added 35.2%	4,749,343 $81.7 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $9.25 Million - $23.9 Million	1,289,505 Added 58.0%	3,512,759 $58.2 Million
Q4 2022 Feb 14, 2023	BUY	$6.74 - $11.52 $1.34 Million - $2.29 Million	198,614 Added 9.81%	2,223,254 $16.9 Million
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $4.37 Million - $6.8 Million	550,190 Added 37.31%	2,024,640 $20.1 Million
Q2 2022 Aug 15, 2022	BUY	$5.21 - $12.14 $4.06 Million - $9.45 Million	778,535 Added 111.87%	1,474,450 $13.4 Million
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $5.11 Million - $11.9 Million	695,915 New	695,915 $7.06 Million
Q4 2019 Feb 13, 2020	SELL	$17.96 - $46.63 $201,152 - $522,256	-11,200 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$20.13 - $32.38 $277,794 - $446,844	-13,800 Reduced 55.2%	11,200 $240,000
Q2 2019 Aug 13, 2019	BUY	$26.97 - $27.55 $674,250 - $688,750	25,000 New	25,000 $674,000

Others Institutions Holding BBIO

# of Institutions

292

Shares Held

175M

Call Options Held

8.66M

Put Options Held

2.76M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.7B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Account

Laurion Capital Management LP Bridge Bio Pharma, Inc. Transaction History